A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder

International Clinical Psychopharmacology

Volumn 12, Issue 3, 1997, Pages 131-136

  Milanfranchi, A ^a   Ravagli, S ^a   Lensi, P ^a   Marazziti, D ^a   Cassano, G B ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Clomipramine; Fluvoxamine; Obsessive compulsive disorder; Serotonin reuptake inhibitors

Indexed keywords

AMITRIPTYLINE; CLOMIPRAMINE; DESIPRAMINE; FLUVOXAMINE; IMIPRAMINE; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANTICHOLINERGIC EFFECT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPULSION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MALE; OBSESSION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TREMOR; URINARY TRACT INFECTION; XEROSTOMIA;

EID: 0030848079     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199705000-00002     Document Type: Article

References (18)

1. Cassano GB and Marazziti D (1992) Is depression a disorder of a receptor superfamily? A critical view of the receptor theory of depression and the appraisal of a new heuristic model. European Journal of Psychiatry, 7, 259-270.
2. Freeman CPL, Trimble MR, Deakin JFW, Stokes TM and Ashford JJ (1994) Fluvoxamine versus clomipramine in the treatment of obsessive-compulsive disorder: a multicentre, randomized double blind, parallel group comparison. Journal of Clinical Psychiatry, 55, 301-307.
3. Goodman WK. Price, L. Rasmussen SA, Delgado PL, Heninger GL and Charney DS (1989a) Efficacy of fluvoxamine in obsessive-compulsive disorder. Archives of General Psychiatry, 46, 36-44.
4. Goodman WK. Price, L. Rasmussen SA, Mazure C, Delgado PL, Fleischman RL, Hill CL, Heninger GL and Charney DS (1989b). The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) I: development, use and reliability. Archives of General Psychiatry, 46, 1006-1016.
5. Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR and Charney DS (1990) Specificity of serotonin reputake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Archives of General Psychiatry, 47, 577-585.
6. Goodman WK, Kozak MJ, Liebowitz M and White KL (1996) Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double blind, placebo controlled trial. International Clinical Psychopharmacology, 11, 21-29.
7. Greist JH, Jenike MA, Robinson D and Rasmussen S (1995) Efficacy of fluvoxamine in obsessive-compulsive disorder: results of a multicentre, double-blind, placebo-controlled trial. European Journal of Clinical Research, 7, 195-204.
8. Guy W (1976) ECDEU Assessment Manual for Psychopharmacology, revised DHEW Publication No 76-338 (ABM) Government Printing Office, Washington.
9. Hamilton M (1960) A rating scale for depression. Journal of Neurology Neurosurgery Psychiatry, 23, 56-62.
10. Jenike MA, Hyman S, Baer L, Holland A, Minichiello WE, Buttolph L, Summergrad P, Seymour R and Ricciardi J (1990) A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. American Journal of Psychiatry, 147, 1209-1215.
11. Lensi P, Cassano GB, Correddu G, Ravagli S, Kunovac JL and Akiskal HS (1996) Obsessive-compulsive disorder: familial development history, symptomology, comorbidity and course with special reference to gender-related differences. British Journal of Psychiatry, 169, 101-107.
12. Marazziti D, Calzeroni A, Sacchetti E and Cassano GB (1992) La biologia dei disturbi dell 'umore [in Italian]. Italian Textbook of Psychiatry, pp. 1681-1701. Masson Italia, Milan.
13. Murphy DL, Pickar DL and Alterman IS (1982) Methods for the quantitative assessment of depressive and manic behaviour. In: The Behaviour of Psychiatric Patients (Eds EI Burdock, A Sudilowsky and S Gershon), pp 355-391. Marcel Dekker, New York.
14. Perse TL, Greist GH, Jefferson JW, Rosenfeld R and Dar R (1987) Fluvoxamine treatment in obsessive-compulsive disorder. American Journal of Psychiatry, 144, 1543-1548.
15. Piccinelli M, Pini S, Bellantuono C and Wilkinson G (1995) Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review. British Journal of Psychiatry, 166, 424-443.
16. Tamimi RR, Mavissakalian MR, Jones B and Olson S (1991) Clomipramine versus fluvoxamine in obsessive-compulsive disorder. Annals of Clinical Psychiatry, 3, 275-279.
17. The Clomipramine Collaborative Study Group (1991) Clomipramine in the treatment of patients with obsessive-compulsive disorder. Archives of General Psychiatry, 48, 730-738.
18. Westenberg HGM, De Leeuw AS and Den Boer JA (1993) Serotonin reuptake blockers in obsessive-compulsive disorder: a controlled trial with fluvoxamine [Abstract]. Paper presented at the First International Conference on Obsessive-Compulsive Disorder, Capri, Italy, March 13-14, 1993. p 116.